{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:47:29Z","timestamp":1786978049309,"version":"build-2736575974"},"reference-count":77,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Health Canada?s Genomics Research and Development Initiative"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nitrosamines (NA) are chemical impurities that are present in tobacco, foods, more recently in some pharmaceuticals and are associated with genotoxicity and carcinogenicity. We evaluated the in vivo mutagenicity of nicotine-derived nitrosamine ketone (NNK) or 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone, a model compound used as an anchor molecule to estimate carcinogenic potency of unknown nitrosamine impurities. Big Blue rats were treated with NNK at doses ranging from 0.001 to 30 mg\/kg for 28 days, following which liver and lung tissue were harvested 3 days later for nuclear genomic DNA isolation. Mutations in liver and lung were assessed with the cII transgene assay and endogenous genomic loci using Duplex Sequencing (DupSeq), a highly validated error-corrected sequencing (ECS) technology. The no genotoxic effect level (NOGEL) was 1 mg\/kg in liver and 0.1 mg\/kg in lung while the benchmark dose (BMD) analysis for cII mutagenicity determined a BMDL50 of 1.3 mg\/kg in liver and 0.12 mg\/kg in lung, consistent with lung being the more sensitive target organ for carcinogenicity for NNK. ECS-derived mutagenicity was highly correlated with cII-derived mutagenicity. Interestingly, the types of mutations formed appeared to be tissue-specific with higher C &amp;gt; T transitions and lower T &amp;gt; G transversions in lung compared to liver, differences that may reflect tissue-specific DNA repair capacity and\/or metabolic differences. Collectively, these data support the use of in vivo mutagenicity data\u2500from both TGR cII and ECS methods\u2500for human health and cancer risk characterization of nitrosamines and for estimating acceptable daily intakes for unknown nitrosamine drug substance related impurities.<\/jats:p>","DOI":"10.1021\/acs.chemrestox.6c00154","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:02:02Z","timestamp":1785870122000},"page":"1571-1583","source":"Crossref","is-referenced-by-count":0,"title":["Differential\nMutagenic Response of Rat Liver and Lung\nto Nicotine-Derived Nitrosamine Ketone (NNK)"],"prefix":"10.1021","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7106-830X","authenticated-orcid":true,"given":"Robert A.","family":"Jolly","sequence":"first","affiliation":[{"name":"Eli Lilly and Company, Lilly Research Laboratories , , ,","place":["Indianapolis, Indiana, United States, 46285"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Noteboom","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Lilly Research Laboratories , , ,","place":["Indianapolis, Indiana, United States, 46285"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle P. M.","family":"LeBlanc","sequence":"additional","affiliation":[{"name":"Health Canada , , , ,","place":["Ottawa, Ontario, Canada, K1A0K9"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marchetti","sequence":"additional","affiliation":[{"name":"Health Canada , , , ,","place":["Ottawa, Ontario, Canada, K1A0K9"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8973-2907","authenticated-orcid":true,"given":"Katie L.","family":"Cavanagh","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Lilly Research Laboratories , , ,","place":["Indianapolis, Indiana, United States, 46285"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheroy","family":"Minocherhomji","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Lilly Research Laboratories , , ,","place":["Indianapolis, Indiana, United States, 46285"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"2","key":"2026081709191777400_cit1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1021\/acs.chemrestox.3c00327","article-title":"Mechanisms of Nitrosamine\nMutagenicity and Their Relationship to Rodent Carcinogenic Potency","volume":"37","author":"Snodin","year":"2024","journal-title":"Chem. Res. Toxicol."},{"key":"2026081709191777400_cit2","unstructured":"Center for Drug Evaluation and Research.\n          \n          Control of Nitrosamine\nImpurities in Human Drugs; U.S. Food and\nDrug Administration, 2024, April 9. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/control-nitrosamine-impurities-human-drugs."},{"key":"2026081709191777400_cit3","unstructured":"European Medicines Agency.\n          \n          Nitrosamine Impurities, 2025. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/post-authorisation\/pharmacovigilance-post-authorisation\/referral-procedures-human-medicines\/nitrosamine-impurities."},{"key":"2026081709191777400_cit4","unstructured":"Health Canada.\n          \n          Nitrosamine Impurities in Medications:\nGuidance [Guidance]: Canada.ca, 2025."},{"key":"2026081709191777400_cit5","doi-asserted-by":"publisher","first-page":"104749","DOI":"10.1016\/j.yrtph.2020.104749","article-title":"Are all nitrosamines\nconcerning? A review of mutagenicity\nand carcinogenicity data","volume":"116","author":"Thresher","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"2026081709191777400_cit6","doi-asserted-by":"publisher","first-page":"100186","DOI":"10.1016\/j.comtox.2021.100186","article-title":"Developing structure-activity relationships\nfor N-nitrosamine\nactivity","volume":"20","author":"Cross","year":"2021","journal-title":"Comput. Toxicol."},{"issue":"23","key":"2026081709191777400_cit7","doi-asserted-by":"publisher","first-page":"15584","DOI":"10.1021\/acs.jmedchem.2c01498","article-title":"Strategies\nfor Assessing Acceptable Intakes for Novel N-Nitrosamines Derived\nfrom Active Pharmaceutical Ingredients","volume":"65","author":"Ponting","year":"2022","journal-title":"J. Med.\nChem."},{"issue":"3","key":"2026081709191777400_cit8","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1021\/acs.joc.0c02774","article-title":"An Organic Chemist\u2019s Guide to N-Nitrosamines:\nTheir Structure, Reactivity, and Role as Contaminants","volume":"86","author":"Beard","year":"2021","journal-title":"J. Org. Chem."},{"issue":"11","key":"2026081709191777400_cit9","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1021\/acs.chemrestox.2c00199","article-title":"What Makes a Potent\nNitrosamine? Statistical Validation of Expert-Derived Structure\u2013Activity\nRelationships","volume":"35","author":"Thomas","year":"2022","journal-title":"Chem. Res. Toxicol."},{"key":"2026081709191777400_cit10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.yrtph.2019.01.007","article-title":"Short commentary\non NDMA (N-nitrosodimethylamine) contamination\nof valsartan products","volume":"103","author":"Snodin","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"7","key":"2026081709191777400_cit11","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1158\/1055-9965.EPI-07-2844","article-title":"Extensive metabolic activation of\nthe tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone\nin smokers","volume":"17","author":"Stepanov","year":"2008","journal-title":"Cancer Epidemiol., Biomarkers Prev."},{"issue":"2","key":"2026081709191777400_cit12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/jnci\/92.2.106","article-title":"Doses of Nicotine\nand Lung Carcinogens\nDelivered to Cigarette Smokers","volume":"92","author":"Djordjevic","year":"2000","journal-title":"J. Natl. Cancer\nInst."},{"key":"2026081709191777400_cit13","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/S0140-6736(05)67725-2","article-title":"Comparative\nRisk Assessment Collaborating Group Causes of cancer in the world:\nComparative risk assessment of nine behavioral and environmental risk\nfactors","volume":"366","author":"Danaei","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"2026081709191777400_cit14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1080\/1357628031000116808","article-title":"The world\nhealth report 2002\u2500reducing risks, promoting healthy life","volume":"16","author":"World Health Organization.","year":"20003","journal-title":"Educ. Health"},{"issue":"6","key":"2026081709191777400_cit15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/carcin\/9.6.875","article-title":"Tobacco-specific nitrosamines,\nan important group of\ncarcinogens in tobacco and tobacco smoke","volume":"9","author":"Hecht","year":"1988","journal-title":"Carcinogenesis"},{"key":"2026081709191777400_cit16","first-page":"419","article-title":"Smokeless tobacco\nand some tobacco-specific N-nitrosamines","volume-title":"IARC Monographs on the Evaluation of Carcinogenic Risks to Humans","author":"International Agency for Research on Cancer.","year":"2007"},{"issue":"2","key":"2026081709191777400_cit17","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3390\/cancers6021138","article-title":"Mechanisms\nof Cancer Induction by\nTobacco-Specific NNK and NNN","volume":"6","author":"Xue","year":"2014","journal-title":"Cancers"},{"issue":"1","key":"2026081709191777400_cit18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.fct.2003.08.006","article-title":"Structure-based\nthresholds of toxicological concern (TTC): Guidance for application\nto substances present at low levels in the diet","volume":"42","author":"Kroes","year":"2004","journal-title":"Food Chem. Toxicol."},{"key":"2026081709191777400_cit19","first-page":"6912","article-title":"Induction\nof lung and exocrine pancreas tumors in F344 rats by tobacco-specific\nand Areca-derived N-nitrosamines","volume":"48","author":"Rivenson","year":"1988","journal-title":"Cancer Res."},{"key":"2026081709191777400_cit20","unstructured":"Carcinogenic Potency Databse (CPDB). https:\/\/cpdb.thomas-slone.org\/gold.html Accessed December 2025."},{"key":"2026081709191777400_cit21","unstructured":"International Council For Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use.\n          \n          ICH M7(R2) Guideline: Assessment and Control\nof DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit\nPotential Carcinogenic Risk\u2500Questions and Answers; International Council For Harmonisation, 2023. https:\/\/database.ich.org\/sites\/default\/files\/M7R2_QAs_Step3_2022_0517-Error%20Corrected.pdf."},{"key":"2026081709191777400_cit22","doi-asserted-by":"publisher","first-page":"106051","DOI":"10.1016\/j.yrtph.2026.106051","article-title":"Ames Concordance\nwith the In Vivo Transgenic\nRodent (TGR) Gene Mutation Assay for NDSRIs and Relative In Vivo TGR Potency with Nitrosamines with Robust Dose-Response\nCarcinogenicity Data","volume":"167","author":"Jolly","year":"2026","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"2026081709191777400_cit23","doi-asserted-by":"publisher","first-page":"105640","DOI":"10.1016\/j.yrtph.2024.105640","article-title":"Determining\nrecommended acceptable\nintake limits for N-nitrosamine impurities in pharmaceuticals: Development\nand application of the Carcinogenic Potency Categorization Approach\n(CPCA)","volume":"150","author":"Kruhlak","year":"2024","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"2026081709191777400_cit24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1021\/acs.chemrestox.2c00380","article-title":"Quantum-Mechanical Approach to Predicting\nthe Carcinogenic\nPotency of N-Nitroso Impurities in Pharmaceuticals\nChem","volume":"36","author":"Kostal","year":"2023","journal-title":"Res. Toxicol."},{"issue":"6","key":"2026081709191777400_cit25","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1021\/acs.chemrestox.4c00087","article-title":"Quantum Mechanical\nAssessment of Nitrosamine Potency","volume":"37","author":"De","year":"2024","journal-title":"Chem. Res.\nToxicol."},{"issue":"8","key":"2026081709191777400_cit26","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1021\/acs.chemrestox.4c00133","article-title":"A Kinetic\nModel for Assessing Potential Nitrosamine Carcinogenicity","volume":"37","author":"Yu","year":"2024","journal-title":"Chem. Res. Toxicol."},{"key":"2026081709191777400_cit27","unstructured":"HESI Global.\n          \n          HESI GTTC Nitrosamines Research\nProgram; Health and Environmental Sciences\nInstitute, 2025. https:\/\/hesiglobal.org\/gttc-nitrosamines Accessed December\n2025."},{"issue":"1","key":"2026081709191777400_cit28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/em.21727","article-title":"Quantitative approaches\nfor assessing dose-response relationships in genetic toxicology studies","volume":"54","author":"Gollapudi","year":"2013","journal-title":"Environ. Mol. Mutagen."},{"key":"2026081709191777400_cit29","unstructured":"International Council For Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use.\n          \n          Assessment and Control of DNA Reactive (Mutagenic)\nImpurities in Pharmaceuticals to Limit Potential Carcinogenicrisk\nM7(R2); International Council For Harmonisation, 2023. https:\/\/database.ich.org\/sites\/default\/files\/ICH_M7%28R2%29_Guideline_Step4_2023_0216_0.pdf."},{"key":"2026081709191777400_cit30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/em.20651","article-title":"Can carcinogenic\npotency be predicted from in vivo genotoxicity data? a meta-analysis\nof historical data","volume":"52","author":"Herna\u0301ndez","year":"2011","journal-title":"Environ. Mol. Mutagen."},{"issue":"6\u20137","key":"2026081709191777400_cit31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/em.22615","article-title":"Assessing the genotoxicity of N-nitrosodiethylamine\nwith three in vivo endpoints in male Big Blue\u00ae\ntransgenic and wild-type C57BL\/6N mice","volume":"65","author":"Zhang","year":"2024","journal-title":"Environ.\nMol. Mutagen."},{"issue":"1","key":"2026081709191777400_cit32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/em.22338","article-title":"Mutation as a Toxicological Endpoint for Regulatory\nDecision-Making","volume":"61","author":"Heflich","year":"2020","journal-title":"Environ. Mol. Mutagen."},{"key":"2026081709191777400_cit33","doi-asserted-by":"publisher","first-page":"33414","DOI":"10.1073\/pnas.2013724117","article-title":"Direct quantification\nof in vivo mutagenesis and carcinogenesis using duplex\nsequencing","volume":"117","author":"Valentine","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026081709191777400_cit34","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12864-022-08752-w","article-title":"Duplex sequencing identifies genomic\nfeatures that\ndetermine susceptibility to benzo(a)pyrene-induced in vivo mutations","volume":"23","author":"LeBlanc","year":"2022","journal-title":"BMC Genomics"},{"key":"2026081709191777400_cit35","doi-asserted-by":"publisher","first-page":"503669","DOI":"10.1016\/j.mrgentox.2023.503669","article-title":"Adopting duplex sequencing\ntechnology for genetic toxicity testing: A proof-of-concept mutagenesis\nexperiment with N-ethyl-N-nitrosourea (ENU)-exposed rats","volume":"891","author":"Smith-Roe","year":"2023","journal-title":"Mutat. Res., Genet. Toxicol. Environ. Mutagen."},{"key":"2026081709191777400_cit36","doi-asserted-by":"publisher","first-page":"108466","DOI":"10.1016\/j.mrrev.2023.108466","article-title":"Error-corrected next generation sequencing\n- Promises\nand challenges for genotoxicity and cancer risk assessment","volume":"792","author":"Marchetti","year":"2023","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"issue":"3","key":"2026081709191777400_cit37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/d41573-023-00014-y","article-title":"Error-corrected next-generation sequencing\nto advance\nnonclinical genotoxicity and carcinogenicity testing","volume":"22","author":"Marchetti","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026081709191777400_cit38","doi-asserted-by":"publisher","first-page":"503685","DOI":"10.1016\/j.mrgentox.2023.503685","article-title":"Comparison of the transgenic rodent mutation assay,\nerror corrected next generation duplex sequencing, and the alkaline\ncomet assay to detect dose-related mutations following exposure to N-nitrosodiethylamine","volume":"891","author":"Bercu","year":"2023","journal-title":"Mutat. Res.\nGenet. Toxicol. Environ. Mutagen"},{"issue":"2","key":"2026081709191777400_cit39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/mutage\/geae001","article-title":"N-Nitrosodimethylamine\ninvestigations in MutaTMMouse define point-of-departure\nvalues and demonstrate less-than-additive somatic mutant frequency\naccumulations","volume":"39","author":"Lynch","year":"2024","journal-title":"Mutagenesis"},{"issue":"5","key":"2026081709191777400_cit40","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/019262339402200510","article-title":"Toxicology and carcinogenesis studies\nof ozone and ozone 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone\nin Fischer-344\/N rats","volume":"22","author":"Boorman","year":"1994","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"2026081709191777400_cit41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/toxsci\/kfab049","article-title":"Toxicokinetic and Genotoxicity\nStudy of NNK in Male Sprague Dawley Rats Following Nose-Only Inhalation\nExposure, Intraperitoneal Injection, and Oral Gavage","volume":"182","author":"Hu","year":"2021","journal-title":"Toxicol. Sci."},{"key":"2026081709191777400_cit42","unstructured":"Organisation for Economic Co-operation and Development.\n          \n          Test No. 488: Transgenic\nRodent Somatic and Germ Cell Gene Mutation Assays; Organisation for Economic Co-operation and Development, 2025, June 25. https:\/\/www.oecd.org\/en\/publications\/test-no-488-transgenic-rodent-somatic-and-germ-cell-gene-mutation-assays_9789264203907-en.html."},{"key":"2026081709191777400_cit43","unstructured":"Agilent Technologies.\n          \n          RecoverEase DNA Isolation\nKit, 2018. https:\/\/www.agilent.com\/cs\/library\/usermanuals\/public\/720202.pdf."},{"key":"2026081709191777400_cit44","unstructured":"Agilent Technologies.\n          \n          \u03bb Select-cII Mutation\nDetection System\nfor Big Blue Rodents, 2015. https:\/\/www.agilent.com\/cs\/library\/usermanuals\/public\/720120.pdf."},{"key":"2026081709191777400_cit45","unstructured":"Agilent Technologies.\n          \n          Transpack Packaging Extract, 2015. https:\/\/www.agilent.com\/cs\/library\/usermanuals\/public\/200220.pdf."},{"key":"2026081709191777400_cit46","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1007\/s00204-023-03527-y","article-title":"Duplex\nsequencing provides detailed characterization of mutation\nfrequencies and spectra in the bone marrow of MutaMouse males exposed\nto procarbazine hydrochloride","volume":"97","author":"Dodge","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"1","key":"2026081709191777400_cit47","doi-asserted-by":"publisher","first-page":"vbaf265","DOI":"10.1093\/bioadv\/vbaf265","article-title":"MutSeqR: an open\nsource R package for standardized analysis of error-corrected next-generation\nsequencing data in genetic toxicology","volume":"5","author":"Dodge","year":"2024","journal-title":"Bioinform.\nAdv."},{"key":"2026081709191777400_cit48","doi-asserted-by":"crossref","unstructured":"Halekoh, U.; H\u00f8jsgaard, S.\n          doBy: Groupwise Statistics,\nLSmeans, Linear Estimates, Utilities. 4.7.0, 2006. 10.32614\/CRAN.package.doBy.","DOI":"10.32614\/CRAN.package.doBy"},{"key":"2026081709191777400_cit49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/genetics\/136.1.403","article-title":"Statistical approaches for analyzing\nmutational spectra:\nsome recommendations for categorical data","volume":"136","author":"Piegorsch","year":"1994","journal-title":"Genetics"},{"key":"2026081709191777400_cit50","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/em.70006","article-title":"Benchmark\nResponse (BMR) Values for In Vivo Mutagenicity Endpoints","volume":"66","author":"White","year":"2025","journal-title":"Environ. Mol. Mutagen."},{"issue":"4","key":"2026081709191777400_cit51","doi-asserted-by":"publisher","DOI":"10.1002\/em.70051","article-title":"Benchmark\nResponse Values for Error-Corrected Sequencing\nMutagenicity Assessment Technologies","volume":"67","author":"Mulugeta","year":"2026","journal-title":"Environ.\nMol. Mutagen."},{"key":"2026081709191777400_cit52","doi-asserted-by":"publisher","first-page":"105835","DOI":"10.1016\/j.yrtph.2025.105835","article-title":"HESI GTTC\nRing Trial: Concordance between Ames and Rodent Carcinogenicity Outcomes\nfor N-Nitrosamines (NAs) with Rat and Hamster Metabolic Conditions","volume":"161","author":"Bercu","year":"2025","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3\u20134","key":"2026081709191777400_cit53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/bf00184666","article-title":"Systemic genotoxic\neffects of tobacco-related\nnitrosamines following oral and inhalational administration to Sprague-Dawley\nrats","volume":"70","author":"Pool-Zobel","year":"1992","journal-title":"Clin. Investig."},{"key":"2026081709191777400_cit54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mrgentox.2018.10.007","article-title":"Evaluation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone\n(NNK) mutagenicity using in vitro and in vivo Pig-a assays","volume":"837","author":"Mittelstaedt","year":"2019","journal-title":"Mutat. Res., Genet.\nToxicol. Environ. Mutagen."},{"key":"2026081709191777400_cit55","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1093\/carcin\/20.11.2167","article-title":"Mutagenesis\ninduced by oral carcinogens in lacZ mouse (MutaTM\nMouse) tongue and other oral tissues","volume":"20","author":"von Pressentin","year":"1999","journal-title":"Carcinogenesis"},{"key":"2026081709191777400_cit56","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/carcin\/22.1.203","article-title":"Mutagenesis\ninduced by 4-methylnitrosamino)-1-(3-pyridyl)-1-butanone-4-(methylnitrosamino)-1-(3-pyridyl)-1\n\u2013 butanone and N-nitrosonornicotine in lacZ upper aerodigestive tissue and liver and inhibition\nby green tea","volume":"22","author":"von Pressentin","year":"2001","journal-title":"Carcinogenesis"},{"issue":"1\u20132","key":"2026081709191777400_cit57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mrgentox.2006.07.003","article-title":"Combined genotoxic\neffects of radiation and a tobacco-specific nitrosamine in the lung\nof gpt delta transgenic mice","volume":"626","author":"Ikeda","year":"2007","journal-title":"Mutat. Res. Genet.\nToxicol. Environ. Mutagen"},{"key":"2026081709191777400_cit58","doi-asserted-by":"publisher","first-page":"112780","DOI":"10.1016\/j.fct.2021.112780","article-title":"90-day nose-only inhalation\ntoxicity study of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)\nin Sprague-Dawley rats","volume":"160","author":"Hu","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"2026081709191777400_cit59","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/carcin\/10.10.1901","article-title":"Rapid single-dose\nmodel for lung\ntumor induction in A\/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone\nand the effect of diet","volume":"10","author":"Hecht","year":"1989","journal-title":"Carcinogenesis"},{"key":"2026081709191777400_cit60","unstructured":"LCDB-Lhasa Carcinogenicity Database. https:\/\/lcdb.lhasacloud.org\/ Accessed Dec 2025."},{"issue":"9","key":"2026081709191777400_cit61","first-page":"801","article-title":"Expression in normal\nhuman tissues of five nucleotide excision repair genes measured simultaneously\nby multiplex reverse transcription-polymerase chain reaction","volume":"8","author":"Cheng","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"5","key":"2026081709191777400_cit62","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.18632\/aging.100866","article-title":"DNA repair\nin species with extreme\nlifespan differences","volume":"7","author":"MacRae","year":"2015","journal-title":"Aging"},{"issue":"8","key":"2026081709191777400_cit63","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/carcin\/21.8.1527","article-title":"Reduced expression\nlevels of nucleotide excision repair genes in lung cancer: A case-control\nanalysis","volume":"21","author":"Cheng","year":"2000","journal-title":"Carcinogenesis"},{"issue":"2","key":"2026081709191777400_cit64","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.mrgentox.2004.02.010","article-title":"Mutations induced by\n4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone\n(NNK) in the lacZ and cII genes of Muta Mouse","volume":"560","author":"Hashimoto","year":"2004","journal-title":"Mutat. Res."},{"key":"2026081709191777400_cit65","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/em.70007","article-title":"Re-Evaluating Acceptable Intake:\nA Comparative Study\nof N-Nitrosomorpholine and N-Nitroso Reboxetine Potency","volume":"66","author":"Zhang","year":"2025","journal-title":"Environ. Mol. Mutagen."},{"issue":"5","key":"2026081709191777400_cit67","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.3390\/ijms24054684","article-title":"DNA Alkylation\nDamage by Nitrosamines and Relevant\nDNA Repair Pathways","volume":"24","author":"Fahrer","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"2026081709191777400_cit68","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0027-5107(90)90161-v","article-title":"Mutagenesis\nby N-nitroso compounds: relationships to DNA adducts, DNA repair,\nand mutational deficiences","volume":"233","author":"Guttenplan","year":"1990","journal-title":"Mutat. Res."},{"key":"2026081709191777400_cit69","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1007\/s00204-025-04103-2","article-title":"Deriving safe\nlimits for N-nitroso-bisoprolol\nby error-corrected next-generation sequencing (ecNGS) and benchmark\ndose (BMD) analysis, integrated with QM modeling and CYP-docking analysis","volume":"99","author":"Simon","year":"2025","journal-title":"Arch. Toxicol."},{"issue":"3","key":"2026081709191777400_cit70","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/em.22479","article-title":"AOP report: Development\nof an adverse outcome pathway for oxidative DNA damage leading to\nmutations and chromosomal aberrations","volume":"63","author":"Cho","year":"2022","journal-title":"Environ.\nMol. Mutagen."},{"key":"2026081709191777400_cit71","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/tc.2010.042192","article-title":"Carcinogenic tobacco-specific N-nitrosamines\nin US cigarettes: three decades of remarkable neglect by the tobacco\nindustry","volume":"21","author":"Stepanov","year":"2012","journal-title":"Tob. Control"},{"issue":"12","key":"2026081709191777400_cit72","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1093\/carcin\/10.12.2269","article-title":"Cell specificity\nfor the pulmonary metabolism of tobacco-specific nitrosamines in the\nFischer rat","volume":"10","author":"Belinsky","year":"1989","journal-title":"Carcinogenesis"},{"key":"2026081709191777400_cit73","doi-asserted-by":"publisher","first-page":"105672","DOI":"10.1016\/j.yrtph.2024.105672","article-title":"Estimation of acceptable\ndaily intake values based\non modeling and in vivo mutagenicity of NDSRIs of\nfluoxetine, duloxetine and atomoxetine","volume":"152","author":"Jolly","year":"2024","journal-title":"Regul.\nToxicol. Pharmacol."},{"issue":"10","key":"2026081709191777400_cit74","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1007\/s00204-025-04121-0","article-title":"Alignment between Duplex Sequencing and transgenic\nrodent mutation assay data in the assessment of in vivo NDMA-induced\nmutagenesis","volume":"99","author":"Ashford","year":"2025","journal-title":"Arch. Toxicol."},{"key":"2026081709191777400_cit75","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/em.22599","article-title":"Severity\nof effect considerations regarding the use\nof mutation as a toxicological endpoint for risk assessment: A report\nfrom the 8th International Workshop on Genotoxicity Testing (IWGT)","author":"Parsons","year":"2025","journal-title":"Environ. Mol. Mutagen."},{"issue":"1\u20133","key":"2026081709191777400_cit76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrrev.2005.04.002","article-title":"Detailed review\nof transgenic rodent mutation assays","volume":"590","author":"Lambert","year":"2005","journal-title":"Mutat.\nRes."},{"key":"2026081709191777400_cit77","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.yrtph.2025.105906","article-title":"Genotoxicity\nevaluation of ten nitrosamine drug substance-related impurities using\n2D and 3D HepaRG cell models","volume":"162","author":"Seo","year":"2025","journal-title":"Regul. Toxicol.\nPharmacol."},{"key":"2026081709191777400_cit78","doi-asserted-by":"publisher","first-page":"105681","DOI":"10.1016\/j.yrtph.2024.105681","article-title":"N-nitrosamine impurity risk assessment\nin pharmaceuticals:\nUtilizing In vivo mutation relative potency comparison to establish\nan acceptable intake for NTTP","volume":"152","author":"Powley","year":"2024","journal-title":"Regul. Toxicol.\nPharmacol."}],"container-title":["Chemical Research in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.chemrestox.6c00154","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/crtoec\/article-pdf\/39\/8\/1571\/66392507\/acs.chemrestox.6c00154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/crtoec\/article-pdf\/39\/8\/1571\/66392507\/acs.chemrestox.6c00154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:42:34Z","timestamp":1786974154000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/crtoec\/article\/39\/8\/1571\/5243587\/Differential-Mutagenic-Response-of-Rat-Liver-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":77,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,4]]},"published-print":{"date-parts":[[2026,8,17]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.chemrestox.6c00154","relation":{},"ISSN":["0893-228X","1520-5010"],"issn-type":[{"value":"0893-228X","type":"print"},{"value":"1520-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}